Magdalen E. Hull

Nafarelin, a gonadotropin-releasing hormone agonist, has been shown to be effective in the treatment of endometriosis. The standard dosage is 200 micrograms bid intranasally. Side effects most commonly include those associated with estrogen…

For nearly a century, endometriosis has remained a fascinating yet controversial disease. Clinical opinion and formal research have influenced our understanding of this ubiquitous medical enigma. Since the 1970s, there has been an appreciab…

Over the past three decades, medical management of endometriosis has included high-dose synthetic estrogen, diethylstilbestrol, androgens, progestins (with or without estrogen), danazol, a synthetic derivative of 17-ethinyl testosterone, an…